Actively Recruiting
The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin
Led by Shanghai Dermatology Hospital · Updated on 2024-07-24
28
Participants Needed
1
Research Sites
5 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin
CONDITIONS
Official Title
The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Sensitive skin with a diagnosis of persistent erythema and a lactate irritation test score of 2-3
- No use of related skin care products including bovine alkaline fibroblast growth factor within 1 month before the study
- No photoelectric treatment measures within 1 month before the study
- Strict use of physical sunscreen during enrollment
- Age between 18 and 60 years
You will not qualify if you...
- Children
- Serious heart, liver, kidney, or blood system diseases, and severe immunocompromise
- Mental illness or cancer
- Use of glucocorticoids, calcineurin inhibitors, topical small molecule drugs, antibiotics, or tretinoin within 3 months
- Allergy to basic fibroblast growth factor gel or its components
- Acute dermatitis of the face and perifolliculitis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Skin Disease Hospital
Shanghai, China
Actively Recruiting
Research Team
H
Haiyan Zhang, MD PhD
CONTACT
X
xiuli Wang, MD PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here